12

resultat

Ord
Publikationstyp
Politikområde
Författare
Sökord
Datum

Protecting workers against carcinogens and mutagens: Third proposal

20-03-2019

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the ...

The European Commission is undertaking a phased process to amend Directive 2004/37/EC (the Carcinogens and Mutagens Directive), expanding its scope and including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The third proposal to amend the directive addresses a further five agents. The agreement on the proposal reached after trilogue negotiations now needs to be confirmed by Parliament, with a vote expected to take place during the March II plenary session.

Limits on exposure to carcinogens and mutagens at work: Second proposal

15-03-2019

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade ...

The European Commission has proposed to amend Directive 2004/37/EC, by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing chemical agents. The initiative is proceeding in steps. The first proposal, submitted in May 2016, covered 13 priority chemical agents. The current (second) proposal addresses a further seven agents. Broad discussions with scientists and the social partners fed into both proposals. On the whole, trade unions and employers welcomed the current proposal. Trilogue agreement was reached on 11 October 2018. As proposed by the European Parliament, diesel engine exhaust emissions were included in the scope of the directive. After completion of the legislative procedure, the final act was signed by the presidents of the co-legislators on 16 January 2019. Directive (EU) 2019/130 entered into force on 20 February 2019 and is to be transposed into national laws within two years, by 20 February 2021 at the latest. Third edition. The ‘EU Legislation in Progress’ briefings are updated at key stages throughout the legislative procedure.

Limits on exposure to carcinogens and mutagens at work: Third proposal

18-02-2019

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three ...

The European Commission has proposed to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer- or mutation-causing substances. The initiative is proceeding in steps. The first proposal of May 2016 covered 13 priority chemical agents, the second, of January 2017, a further seven. The current (third) proposal addresses an additional five. Broad discussions with scientists and the social partners fed into all three proposals. Reacting to the Commission’s set of measures as a whole, trade unions have acknowledged the importance of further improving the existing framework. Actors on the employers’ side have underlined the need to ensure that values are proportionate and feasible in terms of technical implementation. Parliament’s Employment and Social Affairs Committee voted its report on 20 November 2018. It includes the call to bring cytotoxic medicines, which are used in the treatment of cancer, within the scope of the directive, as well as to grant incentives to businesses that comply. Council agreed on its position on 6 December 2018. Trilogue negotiations gave rise to a provisional agreement in January 2019. Once endorsed by the Council, it will be voted in Parliament’s plenary. Second edition. The ‘EU Legislation in Progress’ briefings are updated at key stages throughout the legislative procedure.

Protection of workers from exposure to carcinogens or mutagens: Third proposal

17-12-2018

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research ...

This detailed appraisal focuses on the process and evidence base used in the IA for setting the limit values for cadmium and beryllium, notably in light of some knowledge gaps and methodological challenges identified in the IA in relation to the number of workers exposed and the estimation of the burden of disease. The appraisal concludes that the IA has relied on a vast and updated amount of information, including scientific journals, guidelines, manuals, surveys, published by authoritative research centres, publishers and international organisations, making the overall analysis sufficiently convincing and robust. As regards the limitations of the analysis, which are transparently acknowledged, the analysis carried out by the external contractors and endorsed in the IA recognises that the full current and future disease burden deriving from historic exposures to cadmium and beryllium is not captured; consequently, the disease burdens may be underestimated. As regards the estimated number of workers exposed to cadmium, the value of 10 000 workers considered by the external contractors for their modelling (in addition to a higher value of 30 000), and taken over in the IA, is coherently justified in light of the recognised wide divergences among the different estimates. This value appears to be reasonable, based on the availability of data at national and EU level, and the way some of them were gathered. As regards the estimated number of workers exposed to beryllium, the figure of 54 071 workers exposed in the EU 28 (excluding the construction sector) identified by the external contractor and used in the IA appears to be plausible, based on the justifications provided. However, it is acknowledged that higher exposure levels would imply higher costs and benefits at all target OEL values.

Protection of workers from exposure to carcinogens or mutagens: third proposal

27-06-2018

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent ...

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent with the approach followed in two previous amendments of the directive. The analysis of impacts focuses on the economic and social dimension, mainly health, consistently with the manner in which the problem has been defined. Environmental impacts are assessed to be broadly negligible: considering that the IA is dealing with carcinogenic chemical substances, this would have perhaps required further justification. The IA acknowledges a general issue regarding, inter alia, the availability of data on the number of workers exposed, and the scarce and not always sufficiently robust epidemiological evidence. The methodological annex does not provide information regarding how the multi criteria analysis has been performed. Finally, the IA appears to have addressed most of the RSB's recommendations and the legislative proposal appears to be consistent with the analysis carried out in the IA.

Arbetsmiljö

01-05-2018

Allt sedan 1980-talet har en bättre arbetsmiljö varit en viktig fråga för EU. Unionslagstiftningen har infört minimistandarder för skydd av arbetstagare, medan medlemsstater får behålla eller införa mer långtgående åtgärder. När Lissabonfördraget trädde i kraft blev EU:s stadga om de grundläggande rättigheterna rättsligt bindande, vilket gjorde att arbetsmiljöpolitiken blev en ännu viktigare del av unionslagstiftningen.

Allt sedan 1980-talet har en bättre arbetsmiljö varit en viktig fråga för EU. Unionslagstiftningen har infört minimistandarder för skydd av arbetstagare, medan medlemsstater får behålla eller införa mer långtgående åtgärder. När Lissabonfördraget trädde i kraft blev EU:s stadga om de grundläggande rättigheterna rättsligt bindande, vilket gjorde att arbetsmiljöpolitiken blev en ännu viktigare del av unionslagstiftningen.

Limits on exposure to carcinogens and mutagens at work

22-01-2018

The European Commission proposes to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer-causing chemical agents. According to the Commission, this would improve workers' health protection, increase the effectiveness of the EU framework and promote clarity for economic operators. Overall, the proposal received a broad welcome from stakeholders. After completion of the legislative procedure at first reading in ...

The European Commission proposes to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational exposure limit values for a number of cancer-causing chemical agents. According to the Commission, this would improve workers' health protection, increase the effectiveness of the EU framework and promote clarity for economic operators. Overall, the proposal received a broad welcome from stakeholders. After completion of the legislative procedure at first reading in the European Parliament and the Council, the presidents of the co-legislators signed the final act on 12 December 2017. The directive applies as from 16 January 2018.

Protection of workers from carcinogens or mutagens at work: Exposure limit values

23-10-2017

The European Commission proposes to amend Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (the Carcinogens and Mutagens Directive, CMD) by expanding its scope and by including and/or revising occupational exposure limit values for 13 cancer- and mutation-causing chemicals. Parliament is due to vote on the proposal during the October II plenary.

The European Commission proposes to amend Directive 2004/37/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (the Carcinogens and Mutagens Directive, CMD) by expanding its scope and by including and/or revising occupational exposure limit values for 13 cancer- and mutation-causing chemicals. Parliament is due to vote on the proposal during the October II plenary.

Protection of workers from exposure to carcinogens or mutagens: second proposal (CMD 2)

13-07-2017

The IA defines the problem clearly, and its evolution without EU action is comprehensively outlined. The objectives appear to be relevant, sufficiently measurable, achievable, and consistent with the manner in which the problem has been defined, as well as with other EU policies; however, they are not time-bound. The methodology used to compare the scope of impacts is well-developed, even though it is not always clear how the reported figures were obtained. However, the proposed range of options ...

The IA defines the problem clearly, and its evolution without EU action is comprehensively outlined. The objectives appear to be relevant, sufficiently measurable, achievable, and consistent with the manner in which the problem has been defined, as well as with other EU policies; however, they are not time-bound. The methodology used to compare the scope of impacts is well-developed, even though it is not always clear how the reported figures were obtained. However, the proposed range of options limits the scope of the analysis, and some of those retained for consideration are not entirely convincing. Environmental impacts are claimed not to be significant, without any explanation being provided. There is also a general issue regarding the availability of timely and reliable data, as well as the scarcity of available epidemiologic evidence. The Commission has consulted a broad range of stakeholders, and the replies received were highly representative of all national-level social partner organisations of employers and trade unions. Finally, the IA seems to have addressed the RSB's recommendations.

Limits on exposure to carcinogens and mutagens at work

23-06-2016

The European Commission proposes to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational limit exposure values for a number of cancer-causing chemical agents in the light of new scientific data. According to the Commission, this would improve workers' health protection, increase the effectiveness of the EU framework and promote clarity for economic operators. The initiative would proceed in two steps, with the current proposal and another to follow later ...

The European Commission proposes to amend Directive 2004/37/EC by expanding its scope and by including and/or revising occupational limit exposure values for a number of cancer-causing chemical agents in the light of new scientific data. According to the Commission, this would improve workers' health protection, increase the effectiveness of the EU framework and promote clarity for economic operators. The initiative would proceed in two steps, with the current proposal and another to follow later in the year. Broad discussions with scientists and the social partners fed into the proposal, and it has received a broad welcome from stakeholders. Trade unions nonetheless regret that certain substances are not included, and some on the employers' side oppose the limit value for respirable crystalline silica. The legislative process is in its initial stages, with the EMPL Committee to consider the proposal in the coming months. A more recent edition of this document is available. Find it by searching by the document title at this address: http://www.europarl.europa.eu/thinktank/en/home.html

Kommande evenemang

03-03-2020
Demographic Outlook for the EU in 2020: Understanding population trends in the EU
Övrigt -
EPRS
05-03-2020
Has the EU become a regulatory superpower? How it's rules are shaping global markets
Övrigt -
EPRS

Partner

Håll dig informerad

email update imageE-postuppdateringar

Du kan följa vem eller vad som helst som har med parlamentet att göra med hjälp av systemet med e-postuppdateringar, som ger dig uppdateringar direkt till din inbox. Bl.a. kan du få senaste nytt från ledamöterna, nyhetstjänsterna eller Think Tank.

Du kommer åt systemet från alla sidor på parlamentets webbplats. Vill du anmäla dig och börja ta emot uppdateringarna från Think Tank anger du bara din e-post, vad du är intresserad av och hur ofta du vill få notiserna (varje dag, vecka eller månad) och bekräftar sedan genom att klicka på den länk som skickas till dig i bekräftelsemejlet.

RSS imageRSS-flöden

Följ alla nyheter och uppdateringar på Europaparlamentets webbplats med våra RSS-flöden.

Klicka på länken nedan för att konfigurera dina flöden.